News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Conference News TCT 2017 Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock Yael L. Maxwell November 09, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Conference News TCT 2017 3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike Yael L. Maxwell October 31, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Daily News Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria Caitlin E. Cox October 18, 2017
Presentation Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR October 17, 2017
News Daily News Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR Shelley Wood October 10, 2017
News Daily News Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues Caitlin E. Cox October 06, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Conference News PCR London Valves 2017 Valve Deterioration and Durability Definitions Now Standardized in New Guide Shelley Wood September 25, 2017
News Conference News PCR London Valves 2017 TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis Shelley Wood September 24, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2017 Caitlin E. Cox August 31, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Daily News TAVR in the US: Regional Variations in Numbers, Outcomes Michael O'Riordan August 22, 2017
Presentation Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US August 22, 2017
News Daily News FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall Shelley Wood August 07, 2017